[Systemic juvenile rheumatoid arthritis]. 2007

Mario García-Carrasco, and Salvador Fuentes-Alexandro, and Ricardo O Escárcega, and Jorge Rojas-Rodríguez

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D001171 Arthritis, Juvenile Arthritis in children, with onset before 16 years of age. The terms juvenile rheumatoid arthritis (JRA) and juvenile idiopathic arthritis (JIA) refer to classification systems for chronic arthritis in children. Only one subtype of juvenile arthritis (polyarticular-onset, rheumatoid factor-positive) clinically resembles adult rheumatoid arthritis and is considered its childhood equivalent. Arthritis, Juvenile Chronic,Arthritis, Juvenile Idiopathic,Arthritis, Juvenile Rheumatoid,Childhood Arthritis,PCJIA,PJIA Polyarticular Juvenile Idiopathic Arthritis,Polyarticular Juvenile Idiopathic Arthritis,Polyarticular-Course Juvenile Idiopathic Arthritis,Still's Disease, Juvenile-Onset,Enthesitis-Related Arthritis, Juvenile,Juvenile Chronic Arthritis,Juvenile Idiopathic Arthritis,Juvenile Rheumatoid Arthritis,Juvenile-Onset Still Disease,Juvenile-Onset Stills Disease,Oligoarthritis, Juvenile,Polyarthritis, Juvenile, Rheumatoid Factor Negative,Polyarthritis, Juvenile, Rheumatoid Factor Positive,Psoriatic Arthritis, Juvenile,Still Disease, Juvenile-Onset,Systemic Arthritis, Juvenile,Arthritides, Childhood,Arthritis, Childhood,Arthritis, Juvenile Enthesitis-Related,Arthritis, Juvenile Psoriatic,Arthritis, Juvenile Systemic,Childhood Arthritides,Chronic Arthritis, Juvenile,Enthesitis Related Arthritis, Juvenile,Idiopathic Arthritis, Juvenile,Juvenile Arthritis,Juvenile Enthesitis-Related Arthritis,Juvenile Oligoarthritis,Juvenile Onset Still Disease,Juvenile Onset Stills Disease,Juvenile Psoriatic Arthritis,Juvenile Systemic Arthritis,Juvenile-Onset Still's Disease,Rheumatoid Arthritis, Juvenile,Still Disease, Juvenile Onset,Still's Disease, Juvenile Onset,Stills Disease, Juvenile-Onset
D013792 Thalidomide A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action. Sedoval,Thalomid

Related Publications

Mario García-Carrasco, and Salvador Fuentes-Alexandro, and Ricardo O Escárcega, and Jorge Rojas-Rodríguez
May 1998, Bailliere's clinical rheumatology,
Mario García-Carrasco, and Salvador Fuentes-Alexandro, and Ricardo O Escárcega, and Jorge Rojas-Rodríguez
July 1995, Lancet (London, England),
Mario García-Carrasco, and Salvador Fuentes-Alexandro, and Ricardo O Escárcega, and Jorge Rojas-Rodríguez
January 1989, Revista chilena de pediatria,
Mario García-Carrasco, and Salvador Fuentes-Alexandro, and Ricardo O Escárcega, and Jorge Rojas-Rodríguez
January 2003, Zhonghua er ke za zhi = Chinese journal of pediatrics,
Mario García-Carrasco, and Salvador Fuentes-Alexandro, and Ricardo O Escárcega, and Jorge Rojas-Rodríguez
January 1995, The Journal of rheumatology,
Mario García-Carrasco, and Salvador Fuentes-Alexandro, and Ricardo O Escárcega, and Jorge Rojas-Rodríguez
January 1997, The Journal of rheumatology,
Mario García-Carrasco, and Salvador Fuentes-Alexandro, and Ricardo O Escárcega, and Jorge Rojas-Rodríguez
April 1992, Ryumachi. [Rheumatism],
Mario García-Carrasco, and Salvador Fuentes-Alexandro, and Ricardo O Escárcega, and Jorge Rojas-Rodríguez
November 1989, Arthritis and rheumatism,
Mario García-Carrasco, and Salvador Fuentes-Alexandro, and Ricardo O Escárcega, and Jorge Rojas-Rodríguez
November 1987, Ugeskrift for laeger,
Mario García-Carrasco, and Salvador Fuentes-Alexandro, and Ricardo O Escárcega, and Jorge Rojas-Rodríguez
April 2002, Pediatric neurology,
Copied contents to your clipboard!